Life sciences innovators at all stages seek patent protection to limit market competition and, in some cases, attract further investment. Careful IP planning is especially important in the life sciences, with many companies relying on a handful of patents to protect their high-value products.
It is essential that companies pay close attention to the interrelationship between patent and US Food and Drug Administration (FDA) regulatory considerations to protect their most valuable assets for the long term.
Morrison & Forester is a proud sponsor of LSPN Connect. Join attorneys Brigid Bondoc and Lisa Silverman on Thursday, December 2, at 12pm EST for a LSPN Connect session, “FDA and Patent Strategies for Life Sciences Innovators”.
This webinar will explore:
If you’re not already a member of LSPN Connect, you can register for a Taster Ticket, which gives you complimentary access to 3 sessions.